PAC-1,
315183-21-2,
PAC 1,
PAC1,
Procaspase-3 Activator,
UNII-9LIS8N0B2C,
Procaspase activating compound 1,
9LIS8N0B2C,
Procaspase-3 Activator, PAC-1,
(E)-N'-(3-allyl-2-hydroxybenzylidene)-2-(4-benzylpiperazin-1-yl)acetohydrazide,
MFCD03302441,
W-202300,
(4-Benzylpiperazino)acetic acid-(3-allyl-2-hydroxybenzylidene)hydrazide,
4-(Phenylmethyl)-1-piperazineacetic acid [[2-hydroxy-3-(2-propenyl)phenyl]methylene]hydrazide,
2-(4-benzylpiperazin-1-yl)-N'-[(Z)-(6-oxo-5-prop-2-enylcyclohexa-2,4-dien-1-ylidene)methyl]acetohydrazide,
CID6851947,
PAC-1 pound notPAC1,
AC1NT3IP,
AC1O9ALD,
AC1OA9GH,
CHEMBL591429,
GTPL5238,
BDBM36363,
HMS3263J04,
HMS3650O04,
HMS3677J03,
EX-A2122,
first procaspase activating compound,
Tox21_501241,
NSC743444,
s2738,
ZINC31830150,
AKOS024457180,
BCP9001044,
CCG-222545,
CS-3498,
DB13048,
NSC-743444,
RL03112,
SB17310,
2-(4-Benzylpiperazin-1-yl)-N-((2-hydroxy-3-prop-2-enyl-phenyl)methylideneamino)acetamide,
PAC-1, >=98% (HPLC),
NCGC00167785-01,
NCGC00261926-01,
1-Piperazineacetic acid, 4-(phenylmethyl)-, ((2-hydroxy-3-(2-propenyl)phenyl)methylene)hydrazide,
1-Piperazineacetic acid, 4-(phenylmethyl)-, 2-((2-hydroxy-3-(2-propen-1-yl)phenyl)methylene)hydrazide,
AS-19239,
BC644899,
HY-13523,
BCP0726000262,
RT-014922,
X5905,
Z-3306,
SR-02000000933,
SR-02000000933-2,
BRD-K50841342-001-01-6,
BRD-K92991072-001-01-5,
PAC 1 pound not Procaspase activating compound 1, 315183-21-2,
(4-Benzylpiperazino)acetic acid (3-allyl-2-hyroxybenzylidene)hydrazide,
4-BENZYL-1-PIPERAZINEACETIC ACID [[2-HYDROXY-3-(2-ALLYL)PHENYL]METHYLENE]HYDRAZIDE,
N'-(3-allyl-2-hydroxybenzylidene)-2-(4-benzylpiperazin-1-yl)acEthanolydrazide,
(E)-N'-((5-allyl-6-oxocyclohexa-2,4-dien-1-ylidene)methyl)-2-(4-benzylpiperazin-1-yl)acetohydrazide,
1-Piperazineacetic acid, 2-(phenylmethyl)-,[[2-hydroxy-3-(2-propenyl)phenyl]methylene]hyrrazide,
2-(4-benzylpiperazin-1-yl)-N'-[(1E)-[2-hydroxy-3-(prop-2-en-1-yl)phenyl]methylidene]acetohydrazide,
2-(4-benzylpiperazin-1-yl)-N'-[(1Z)-[2-hydroxy-3-(prop-2-en-1-yl)phenyl]methylidene]acetohydrazide,
2-(4-benzylpiperazin-1-yl)-N'-[(6-oxo-5-prop-2-enylcyclohexa-2,4-dien-1-ylidene)methyl]acetohydrazide,
2-(4-benzylpiperazin-1-yl)-N'-[(E)-(6-oxo-5-prop-2-enylcyclohexa-2,4-dien-1-ylidene)methyl]acetohydrazide,
CBMicro_035200,
D01YIF,
cc-276,
C23H28N4O2,
XSGXRYNZNGUGEJ-LTGZKZEYSA-N,
CID5344054,
CID6753378,
A8177,
A11090,
PAC-1, 98%, a procaspase-3 activatior - 25MG 25mg,
1044929-62-5,